Turnstone Biologics (TSBX) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free TSBX Stock Alerts $2.76 -0.14 (-4.83%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Turnstone Biologics Short Interest DataCurrent Short Volume629,900 sharesPrevious Short Volume625,900 sharesChange Vs. Previous Month+0.64%Dollar Volume Sold Short$1.77 millionShort Interest Ratio / Days to Cover3.3Last Record DateApril 15, 2024Outstanding Shares23,130,000 sharesFloat Size13,230,000 sharesShort Percent of Float4.76%Today's Trading Volume130,089 sharesAverage Trading Volume182,757 sharesToday's Volume Vs. Average71% Short Selling Turnstone Biologics ? Sign up to receive the latest short interest report for Turnstone Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTSBX Short Interest Over TimeTSBX Days to Cover Over TimeTSBX Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Turnstone Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024629,900 shares $1.77 million +0.6%4.8%3.3 $2.81 3/31/2024625,900 shares $1.64 million +42.9%4.7%3.5 $2.62 3/15/2024438,000 shares $1.45 million +11.7%3.3%2.7 $3.32 2/29/2024392,200 shares $1.79 million +14.6%2.7%2.9 $4.56 2/15/2024342,300 shares $718,830.00 -5.4%2.4%2.7 $2.10 1/31/2024361,800 shares $951,534.00 No Change2.5%3.3 $2.63 TSBX Short Interest - Frequently Asked Questions What is Turnstone Biologics' current short interest? Short interest is the volume of Turnstone Biologics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 629,900 shares of TSBX short. 4.76% of Turnstone Biologics' shares are currently sold short. Learn More on Turnstone Biologics' current short interest. What is a good short interest ratio for Turnstone Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSBX shares currently have a short interest ratio of 3.0. Learn More on Turnstone Biologics's short interest ratio. What is a good short interest percentage for Turnstone Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.76% of Turnstone Biologics' floating shares are currently sold short. Is Turnstone Biologics' short interest increasing or decreasing? Turnstone Biologics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 629,900 shares, an increase of 0.6% from the previous total of 625,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Turnstone Biologics' float size? Turnstone Biologics currently has issued a total of 23,130,000 shares. Some of Turnstone Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Turnstone Biologics currently has a public float of 13,230,000 shares. How does Turnstone Biologics' short interest compare to its competitors? 4.76% of Turnstone Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Turnstone Biologics: Ikena Oncology, Inc. (5.48%), Aligos Therapeutics, Inc. (0.87%), Entera Bio Ltd. (0.31%), Cidara Therapeutics, Inc. (0.18%), Instil Bio, Inc. (0.23%), AVROBIO, Inc. (0.36%), Elutia Inc. (0.19%), Genenta Science S.p.A. (0.02%), Cognition Therapeutics, Inc. (0.73%), Gritstone bio, Inc. (13.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Turnstone Biologics stock? Short selling TSBX is an investing strategy that aims to generate trading profit from Turnstone Biologics as its price is falling. TSBX shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Turnstone Biologics? A short squeeze for Turnstone Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TSBX, which in turn drives the price of the stock up even further. How often is Turnstone Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSBX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ikena Oncology Short Interest Data Aligos Therapeutics Short Interest Data Entera Bio Short Interest Data Cidara Therapeutics Short Interest Data Instil Bio Short Interest Data AVROBIO Short Interest Data Elutia Short Interest Data Genenta Science Short Interest Data Cognition Therapeutics Short Interest Data Gritstone bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TSBX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry